NATIVIDAD NERI MUÑOZ



DATOS GENERALES
Nombre completo   NATIVIDAD NERI MUÑOZ
Máximo nivel de estudios   LICENCIATURA
Antigüedad académica en la UNAM   5 años
NOMBRAMIENTOS
Último  PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Medicina
PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Medicina
Desde 16-09-2012 hasta 15-03-2018
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI I2014 - 2023
* PEPASIG Nivel A (Licenciatura)2015 - 2016, 3 horas asignadas

INFORMACIÓN DE PUBLICACIONES
Firmas  
Neri N.
Áreas de conocimiento  
Hematology Oncology Pharmacology and pharmacy Radiology, nuclear medicine and medical imaging Hematology
Medicine (miscellaneous) Oncology Radiology, Nuclear Medicine and Imaging
Coautorías con entidades de la UNAM  
  • Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas
  • Facultad de Medicina
Revistas en las que ha publicado  (16):
  1. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, Estados Unidos America (2012)
  2. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, Estados Unidos America (2015)
  3. CLINICAL & TRANSLATIONAL ONCOLOGY, Italia (2020)
  4. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Estados Unidos America (2016, 2017)
  5. CURRENT ONCOLOGY, Canada (2013)
  6. Frontiers in Oncology, Suiza (2020)
  7. Hematology, Reino Unido (2015)
  8. INTERNATIONAL JOURNAL OF CANCER, Estados Unidos America (2012, 2013)
  9. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, Estados Unidos America (2012)
  10. JAMA oncology, Estados Unidos America (2017)
  11. Journal of Oncology Pharmacy Practice, Reino Unido (2019)
  12. JPN J CLIN ONCOL, Japón (2017)
  13. MEDICAL ONCOLOGY, Estados Unidos America (2013)
  14. Mediterranean Journal of Hematology and Infectious Diseases, Italia (2018)
  15. Oncotarget, Estados Unidos America (2019)
  16. Precision Radiation Oncology, (2018, 2019)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1Coautor: Neri N., Morales-Martinez M., Vega G.G., Nambo M.J., et al.2020Frontiers in OncologyWoS-id: 000588045500001
Scopus-id: 2-s2.0-85095833552
1016
2A new therapeutic approach in very refractory diffuse large B-cell lymphomaCoautor: Neri N., Avilés A., Nambo M.-J., Cleto S., et al.2020CLINICAL & TRANSLATIONAL ONCOLOGYScopus-id: 2-s2.0-85069927313
00
3Primary gastric diffuse large B-cell lymphoma: The role of dose-dense chemotherapyCoautor y autor de correspondencia: Neri N., Avilés A., Nambo M.-J.2019Journal of Oncology Pharmacy PracticeWoS-id: 000482977300019
Scopus-id: 2-s2.0-85059308002
34
4Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphomaCoautor: Neri N., Morales-Martinez M., Valencia-Hipolito A., Vega G.G., et al.2019OncotargetScopus-id: 2-s2.0-85063965942
024
5Role of radiotherapy in diffuse large B-cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximabCoautor: Neri N., Aviles A., Calva A., Cleto S., et al.2019Precision Radiation OncologyScopus-id: 2-s2.0-85089890751
04
6Radiotherapy after immunochemotherapy improves outcomes in patients with primary mediastinal large B-cell lymphomaCoautor: Neri N., Avilés A., Calva A., Cleto S., et al.2019Precision Radiation OncologyScopus-id: 2-s2.0-85106132835
03
7Treatment of early stages Hodgkin lymphoma during pregnancyCoautor y autor de correspondencia: Neri N., Avilés A., Nambo M.-J.2018Mediterranean Journal of Hematology and Infectious DiseasesWoS-id: 000418953300006
Scopus-id: 2-s2.0-85040511985
1213
8Risk of a second neoplasm on long-term survivors of Hodgkin's lymphomaCoautor: Neri N., Aviles A., Nambo M.-J., Calva A.2018Precision Radiation OncologyScopus-id: 2-s2.0-85106097639
00
9Lymphoma and pregnancyCoautor y autor de correspondencia: Neri N., Avilés A., Nambo M.-J.2017JAMA oncologyWoS-id: 000399425800025
Scopus-id: 2-s2.0-85020103453
00
10Prolonged Use of Zoledronic Acid (4 Years) Did Not Improve Outcome in Multiple Myeloma PatientsCoautor: Neri N., Avilès A., Nambo M.-J., Huerta-Guzmàn J., et al.2017CLINICAL LYMPHOMA MYELOMA & LEUKEMIAWoS-id: 000401046300003
Scopus-id: 2-s2.0-85015640693
1111
11Lymphoma and pregnancyCoautor y autor de correspondencia: Neri N., Aviles A., Nambo M.-J.2017JPN J CLIN ONCOLScopus-id: 2-s2.0-85027138228
01
12Speckle-Tracking Echocardiography to Detect Cardiac Toxicity in Children Who Received Anthracyclines during PregnancyCoautor: Neri N., Avilès A., Nambo M.-J., Huerta-Guzmàn J., et al.2016CLINICAL LYMPHOMA MYELOMA & LEUKEMIAWoS-id: 000369557400001
Scopus-id: 2-s2.0-84952876413
79
13Rituximab as consolidation therapy did not improve outcome in patients with diffuse large B-cell lymphoma at complete response after dose-dense chemotherapy (CHOP-14)Coautor: Neri N., Avilès A., Nambo M.-J., Huerta-Guzmàn J., et al.2015CANCER BIOTHERAPY AND RADIOPHARMACEUTICALSWoS-id: 000352954500001
Scopus-id: 2-s2.0-84934759967
00
14Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous t-cell lymphoma2ᵒ autor: Neri N., Aviles A., Fernandez-Diez J., Silva L., et al.2015HematologyWoS-id: 000362601900008
Scopus-id: 2-s2.0-84943613110
2427
15Author's reply: Chemotherapy during first trimester of pregnancy2ᵒ autor: Neri N., Avilés A., Nambo M.J.2013INTERNATIONAL JOURNAL OF CANCERWoS-id: 000314177500033
Scopus-id: 2-s2.0-84873085828
32
16Randomized clinical trial of zoledronic acid in multiple myeloma patients undergoing high-dose chemotherapy and stem-cell transplantation2ᵒ autor: Neri N., Avilés A., Huerta-Guzmán J., Nambo M.J.2013CURRENT ONCOLOGYWoS-id: 000314352400003
Scopus-id: 2-s2.0-84873502317
1920
17Combined therapy in untreated patients improves outcome in Nasal NK/T lymphoma: Results of a clinical trial2ᵒ autor: Neri N., Avilés A., Fernández R., Huerta-Guzmán J., et al.2013MEDICAL ONCOLOGYWoS-id: 000323662900048
Scopus-id: 2-s2.0-84892396619
2227
18Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: An analysis of 3,258 patients in a single centerCoautor y autor de correspondencia: Neri N., Avilés A., Jesús Nambo M.2013MEDICAL ONCOLOGYScopus-id: 2-s2.0-84874371590
016
19The role of genotype in 104 cases of diffuse large B-Cell lymphoma primary of breast2ᵒ autor: Neri N., Aviles A., Nambo M.J.2012AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSWoS-id: 000301956300006
Scopus-id: 2-s2.0-84860696115
1833
20Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma2ᵒ autor: Neri N., Avilés A., Fernández R., Huerta-Guzmán J., et al.2012INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSWoS-id: 000305423400043
Scopus-id: 2-s2.0-84862650010
810
21Hematological malignancies and pregnancy: Treat or no treat during first trimester2ᵒ autor: Neri N., Avilés A., Nambo M.-J.2012INTERNATIONAL JOURNAL OF CANCERWoS-id: 000309185400023
Scopus-id: 2-s2.0-84867055013
4759
Descargar PDF

Obras con ISBN (Indautor)

# Título del documento Autores Alcance Año ISBN Fuente
1Guía De Práctica Clínica Linfomas No Hodgkin En El AdultoNeri Muñoz, Natividad, Libro Completo20129786078270460INDAUTOR
Descargar PDF

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Tratamiento de la enfermedad de Hodgkin en etapas avanzadas y factores pronosticos desfavorables : EVBD comparado con Stanford modificadoTesis de EspecialidadNATIVIDAD NERI MUÑOZ; Zalapa Velazquez, Rita; 2001
2Estudio piloto : tratamiento del linfoma folicular en etapa avanzada, COPP comparado con COPP alterno con interferon Alfa 2BTesis de EspecialidadNATIVIDAD NERI MUÑOZ; Perez Martinez, Mario Aquilino; 2000